skip to main content
Language:
Results 1 2 3 4 5 next page
Refined by: subject: Heart Failure - Complications remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Material Type:
Article
Add to My Research

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

The New England journal of medicine, 2022-09, Vol.387 (12), p.1089-1098 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2206286 ;PMID: 36027570

Full text available

2
Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF
Material Type:
Article
Add to My Research

Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF

Circulation (New York, N.Y.), 2022-09, Vol.146 (13), p.980-994 [Peer Reviewed Journal]

2022 The Authors. 2022 ;ISSN: 0009-7322 ;ISSN: 1524-4539 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.122.060511 ;PMID: 35971840

Full text available

3
Third Universal Definition of Myocardial Infarction
Material Type:
Article
Add to My Research

Third Universal Definition of Myocardial Infarction

Journal of the American College of Cardiology, 2012-10, Vol.60 (16), p.1581-1598 [Peer Reviewed Journal]

European Society of Cardiology, American College of Cardiology Foundation, American Heart Association, Inc., and the World Heart Federation ;2012 European Society of Cardiology, American College of Cardiology Foundation, American Heart Association, Inc., and the World Heart Federation ;2015 INIST-CNRS ;Copyright Elsevier Limited Oct 16, 2012 ;ISSN: 0735-1097 ;ISSN: 1558-3597 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2012.08.001 ;PMID: 22958960 ;CODEN: JACCDI

Full text available

4
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
Material Type:
Article
Add to My Research

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

European heart journal, 2012-07, Vol.33 (14), p.1787-1847 [Peer Reviewed Journal]

ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehs104 ;PMID: 22611136

Full text available

5
Letter to editor: Impact of COVID-19 infection on clinical outcomes among patients with acute decompensated heart failure: A nationwide analysis
Material Type:
Article
Add to My Research

Letter to editor: Impact of COVID-19 infection on clinical outcomes among patients with acute decompensated heart failure: A nationwide analysis

Current problems in cardiology, 2024-04, Vol.49 (4), p.102208 [Peer Reviewed Journal]

EISSN: 1535-6280 ;DOI: 10.1016/j.cpcardiol.2023.102208 ;PMID: 37993006

Digital Resources/Online E-Resources

6
Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction
Material Type:
Article
Add to My Research

Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction

Journal of the American College of Cardiology, 2017-11, Vol.70 (20), p.2490-2500 [Peer Reviewed Journal]

2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Nov 14, 2017 ;ISSN: 0735-1097 ;ISSN: 1558-3597 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2017.09.027 ;PMID: 29145948

Full text available

7
Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HF
Material Type:
Article
Add to My Research

Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HF

European journal of heart failure, 2022-06, Vol.24 (6), p.1066 [Peer Reviewed Journal]

2022 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.2433 ;PMID: 35064721

Digital Resources/Online E-Resources

8
Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
Material Type:
Article
Add to My Research

Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

The New England journal of medicine, 2011-07, Vol.365 (1), p.32-43 [Peer Reviewed Journal]

Copyright © 2011 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1100171 ;PMID: 21732835 ;CODEN: NEJMAG

Full text available

9
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Material Type:
Article
Add to My Research

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

The Lancet (British edition), 2010-09, Vol.376 (9744), p.875-885 [Peer Reviewed Journal]

Elsevier Ltd ;2010 Elsevier Ltd ;2015 INIST-CNRS ;Copyright 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Sep 11-Sep 17, 2010 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)61198-1 ;PMID: 20801500 ;CODEN: LANCAO

Full text available

10
Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals
Material Type:
Article
Add to My Research

Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals

The Lancet (British edition), 2018-02, Vol.391 (10120), p.572-580 [Peer Reviewed Journal]

2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Feb 10, 2018 ;2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2018 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)32520-5 ;PMID: 29174292

Full text available

11
Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial
Material Type:
Article
Add to My Research

Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial

Circulation (New York, N.Y.), 2021-04, Vol.143 (14), p.1377-1390 [Peer Reviewed Journal]

ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.120.050991 ;PMID: 33554614

Full text available

12
Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic
Material Type:
Article
Add to My Research

Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic

Circulation (New York, N.Y.), 2020-08, Vol.142 (5), p.429-436 [Peer Reviewed Journal]

2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.120.048360 ;PMID: 32418446

Full text available

13
Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations
Material Type:
Article
Add to My Research

Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations

Circulation (New York, N.Y.), 2016-06, Vol.133 (24), p.2459-2502 [Peer Reviewed Journal]

2016 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2016 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.116.022194 ;PMID: 27297342

Full text available

14
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
Material Type:
Article
Add to My Research

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

The Lancet (British edition), 2010-09, Vol.376 (9744), p.886-894 [Peer Reviewed Journal]

Elsevier Ltd ;2010 Elsevier Ltd ;2015 INIST-CNRS ;Copyright 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Sep 11-Sep 17, 2010 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)61259-7 ;PMID: 20801495 ;CODEN: LANCAO

Full text available

15
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Material Type:
Article
Add to My Research

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

The New England journal of medicine, 2020-10, Vol.383 (15), p.1413-1424 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2022190 ;PMID: 32865377

Full text available

16
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Material Type:
Article
Add to My Research

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC

European journal of heart failure, 2016-08, Vol.18 (8), p.891-975 [Peer Reviewed Journal]

ISSN: 1388-9842 ;ISSN: 1879-0844 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.592 ;PMID: 27207191

Full text available

17
Sleep apnoea in congestive heart failure: one step forwards
Material Type:
Article
Add to My Research

Sleep apnoea in congestive heart failure: one step forwards

The lancet respiratory medicine, 2024-02, Vol.12 (2), p.94 [Peer Reviewed Journal]

EISSN: 2213-2619 ;DOI: 10.1016/S2213-2600(23)00377-6 ;PMID: 38142696

Digital Resources/Online E-Resources

18
Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
Material Type:
Article
Add to My Research

Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure

The New England journal of medicine, 2019-02, Vol.380 (6), p.539-548 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1812851 ;PMID: 30415601

Full text available

19
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
Material Type:
Article
Add to My Research

Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

The New England journal of medicine, 2023-09, Vol.389 (12), p.1069-1084 [Peer Reviewed Journal]

Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2306963 ;PMID: 37622681

Full text available

20
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Material Type:
Article
Add to My Research

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

The New England journal of medicine, 2019-11, Vol.381 (21), p.1995-2008 [Peer Reviewed Journal]

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1911303 ;PMID: 31535829

Full text available

Personalize your results

  1. Edit

Refine Search Results

Refine My Results

New Records 

  1. New From Last Month  (9)
  2. New From Last 3 Month  (64)
  3. More options open sub menu

Language 

  1. English  (14,226)
  2. Japanese  (1,516)
  3. German  (482)
  4. French  (332)
  5. Russian  (322)
  6. Spanish  (290)
  7. Italian  (266)
  8. Portuguese  (152)
  9. Polish  (114)
  10. Chinese  (71)
  11. Romanian  (49)
  12. Czech  (30)
  13. Dutch  (25)
  14. Danish  (22)
  15. Turkish  (19)
  16. Hungarian  (17)
  17. Norwegian  (17)
  18. Hebrew  (16)
  19. Croatian  (16)
  20. Serbian  (13)
  21. More options open sub menu

Searching Remote Databases, Please Wait